Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Gene Logic Inc. (NASDAQ:GLGC) announced today that it will release Third Quarter 2006 financial results on Thursday, November 9...
Gene Logic Inc. (NASDAQ: GLGC) announced today that it has entered into a drug repositioning and development agreement with Eli...
Gene Logic Inc. (NASDAQ:GLGC) today announced findings of the business review it has conducted over the last 90 days. ? Drug Repositioning: Gene...
Gene Logic Inc. (NASDAQ:GLGC) announced today that it entered into an agreement with the United States Food and Drug Administration ("FDA") to...
Gene Logic Inc. (NASDAQ: GLGC) today reported financial results for the second quarter ended June 30, 2006. -0- *T Revenue (Amounts in thousands...
Gene Logic Inc. (NASDAQ:GLGC) announced today that it has initiated a plan to reduce the number of employees in its Genomics Division and related...
Gene Logic Inc. (NASDAQ:GLGC) announced today that it will release Second Quarter 2006 financial results on Friday, August 4, 2006 at 7:00 a.m...
Gene Logic Inc. (NASDAQ:GLGC) announced today that revenue for its Genomics Division will be significantly lower than previously anticipated for...
Gene Logic Inc. (NASDAQ:GLGC) and Organon announced today that they have entered into a drug repositioning agreement to seek alternative...
Gene Logic Inc. (NASDAQ:GLGC) today reported financial results for the first quarter ended March 31, 2006. ? Revenue ? Total revenue for the...
Gene Logic Inc. (NASDAQ:GLGC) announced today that it will release First Quarter 2006 financial results on Friday, April 21, 2006 at 7:00 a.m...
Gene Logic Inc. (NASDAQ:GLGC) announced today the appointment of Mark T. Crane as vice president, Marketing and Business Development for Gene...
DRS Business Signs Drug Repositioning Agreement with Roche ? Gene Logic Inc. (NASDAQ:GLGC) today reported financial results for the fourth...
Gene Logic Inc. (NASDAQ:GLGC) today announced the completion of significant enhancements to its industry-leading gene expression capabilities...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지